Articles that mention Pricing -BoardProspects

Pricing

0 Comments Leave a Comment

1-11 of 11
1. Mentioned In 11 Articles
2. The Coming Shift in Shareholder Activism: From “Firm-Specific” to “Systematic Risk” Proxy Campaigns (and How to Enable Them)
  
  Explore corpgov.law.harvard.edu Sep 8 2021 BoardBlogs
  
  ...According to the Capital Asset Pricing Model, the goal of these investors should be to seek to reduce their exposure to systematic risk (which is defined as the risk that remains in any portfolio after it is fu...
  Read Full Article
  
  Comment
  
  Mentions: Pricing Risk Shareholder Activism
3. Carlyle Inks $4.1 Billion Credit Line Linked to Board Diversity
  
  Explore Start Magazine Feb 17 2021 BoardNews
  
  ...sity goals. The buyout firm has structured the revolver for its Americas corporate private equity funds, with pricing of the debt depending on whether they meet a previously set target of 30% diverse directors on their b...
  Read Full Article
  
  Comment
  
  Mentions: Carlyle Bloomberg Pricing
4. Investors Continue To Deserve More: From Boards And Courts On Mutual Fund Fees
  
  Explore corpgov.law.harvard.edu May 30 2020 BoardBlogs
  
  ...petitive market works, and the producer of the $50 oranges above will soon be looking for a new line of work. Pricing in the fund industry, however, is not so limited by competitive forces.(go back) 7Research continues t...
  Read Full Article
  
  Comment
  
  Mentions: Investment stake Pricing
5. Activist Investor Starboard Takes Stake in Dollar Tree, Seeks Changes
  
  Explore MarketWatch Jan 7 2019 BoardNews
  
  ...aken a stake in Dollar Tree Inc. and is pushing the retailer to sell its Family Dollar business and tweak its pricing model, according to people familiar with the matter. The New York hedge fund has a 1.7% stake in Dolla...
  Read Full Article
  
  Comment
  
  Mentions: Hedge Fund stake Pricing
6. Patients Versus Shareholders
  
  Explore Stock Market News & Financial Analysis Oct 14 2018 BoardBlogs
  
  ...FDA approved drugs that had to be pulled from the market as it turned out they produced serious side-effects. Pricing is another issue where the US healthcare tends to be rather murky. Prices for similar procedures can v...
  Read Full Article
  
  Comment
  
  Mentions: Mylan Harvard Bloomberg
7. IRS Guidance on Exec Comp Changes Falls Short
  
  Explore ww2.cfo.com Aug 24 2018 BoardBlogs
  
  However, the guidance doesnt really address a lot of the meaty issues, says Andrew Liazos, leader of the executive compensation group for law firm McDermott Will Emery. Its expected that regulations eventually will be proposed to fill the gaps, but that will take awhile, laments Liazos, who posted a summary analysis of the guidance on Thursday...
  Read Full Article
  
  Comment
  
  Mentions: CFO Tax Reform Pricing
8. World's 50 Greatest Leaders
  
  Explore fortune.com May 21 2018 BoardBlogs
  
  ...nts that help the World Food Programme feed 80 million people a year. As cochair of groups such as the Carbon Pricing Leadership Coalition, Sijbesma has proved particularly effective at rallying fellow executives. In muc...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Management Google
9. 23% of Bristol Myers-Squibb Shareholders Back Proposal About Drug Pricing, Compensation
  
  Explore Pensions & Investments May 1 2018 BoardNews
  
  "Our resolution asked how these very real concerns are being incorporated into corporate governance policies on executive compensation and, importantly, if these policies and practices are consistent with our company's stated mission of 'providing access to prescription medicines at fair prices,'" said...
  Read Full Article
  
  Comment
  
  Mentions: Pricing stock options Bristol Myers-Squibb
10. Investors in AbbVie, Lilly, Amgen and More Set to Vote on Executive Pay, drug pricing
  
  Explore Pharma News Mar 26 2018 BoardNews
  
  ...ailing their list price hikes and level of rebating to drug middlemen. A common industry defense against drug pricing criticism is that middlemen are taking a larger share of spending than they have in the past. As lawma...
  Read Full Article
  
  Comment
  
  Mentions: Investment Bristol-Myers Squibb Pricing
11. Sanofi is Buying Another Blood-Disease Biotech for $4.8 Billion
  
  Explore Business Insider Jan 29 2018 BoardNews
  
  ...lowing news the French company was paying far more for a business than Novo had offered just a few weeks ago. Pricing considerations were offset by relief that Sanofi was finally taking action to improve its drugs portfo...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi acquisition Morgan Stanley
12. Big Pharma Is Urged to Report on Links Between Pricing and Pay
  
  Explore Bloomberg Dec 13 2017 BoardNews
  
  .... The ... Pharmaceutical companies should be required to regularly report whether there’s a link between drug-pricing strategies and executive-compensation plans, according to a shareholder group. The Interfaith Center o...
  Read Full Article
  
  Comment
  
  Mentions: Bloomberg Pricing Pharmaceutical Companies
13. 1-11 of 11